- Home
- CRBP vs NEOV Comparison
CRBP vs NEOV Comparison
Compare CRBP & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- NEOV
- Stock Information
- Founded
- CRBP 2009
- NEOV 2018
- Country
- CRBP United States
- NEOV United States
- Employees
- CRBP N/A
- NEOV N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- NEOV Industrial Machinery/Components
- Sector
- CRBP Health Care
- NEOV Miscellaneous
- Exchange
- CRBP Nasdaq
- NEOV Nasdaq
- Market Cap
- CRBP 73.4M
- NEOV 72.2M
- IPO Year
- CRBP N/A
- NEOV N/A
- Fundamental
- Price
- CRBP $6.65
- NEOV $3.37
- Analyst Decision
- CRBP Strong Buy
- NEOV Strong Buy
- Analyst Count
- CRBP 10
- NEOV 1
- Target Price
- CRBP $53.56
- NEOV $7.50
- AVG Volume (30 Days)
- CRBP 148.0K
- NEOV 231.5K
- Earning Date
- CRBP 05-06-2025
- NEOV 05-16-2025
- Dividend Yield
- CRBP N/A
- NEOV N/A
- EPS Growth
- CRBP N/A
- NEOV N/A
- EPS
- CRBP N/A
- NEOV N/A
- Revenue
- CRBP N/A
- NEOV $2,524,931.00
- Revenue This Year
- CRBP N/A
- NEOV $85.10
- Revenue Next Year
- CRBP $150.00
- NEOV $281.25
- P/E Ratio
- CRBP N/A
- NEOV N/A
- Revenue Growth
- CRBP N/A
- NEOV N/A
- 52 Week Low
- CRBP $4.64
- NEOV $1.80
- 52 Week High
- CRBP $61.90
- NEOV $6.11
- Technical
- Relative Strength Index (RSI)
- CRBP 48.86
- NEOV 65.53
- Support Level
- CRBP $6.10
- NEOV $3.09
- Resistance Level
- CRBP $8.07
- NEOV $3.74
- Average True Range (ATR)
- CRBP 0.70
- NEOV 0.37
- MACD
- CRBP -0.07
- NEOV 0.10
- Stochastic Oscillator
- CRBP 26.50
- NEOV 80.11
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.